Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juha Lund

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Plos One|August 10, 2021
Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational StudyKerstin Piayda, Shazia Afzal, Jens Erik Nielsen-Kudsk, et al.
Annals of Medicine|May 3, 2014
Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trialWail Nammas, M J Pekka Raatikainen, Petri Korkeila, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Direct Immunoassay for Free Pregnancy-Associated Plasma Protein A (PAPP-A)Emilia Tuunainen, Juha Lund, Joanna Danielsson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 26, 2021
Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market StudyAdel Aminian, Ole De Backer, Jens Erik Nielsen-Kudsk, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 10, 2017
Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up studyJens Erik Nielsen-Kudsk, Søren Paaske Johnsen, Per Wester, et al.
JACC. Cardiovascular Interventions|May 20, 2019
Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational StudyAdel Aminian, Boris Schmidt, Patrizio Mazzone, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 6, 2020
Comparative data on left atrial appendage occlusion efficacy and clinical outcomes by age group in the Amplatzer™ Amulet™ Occluder Observational StudyXavier Freixa, Boris Schmidt, Patrizio Mazzone, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 11, 2019
Ablation strategies for different types of atrial fibrillation in Europe: results of the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term registryBoris Schmidt, Josep Brugada, Elena Arbelo, et al.
JACC. Cardiovascular Interventions|September 25, 2020
The Impact of CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet StudyGiuseppe Tarantini, Gianpiero D'Amico, Boris Schmidt, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 27, 2017
Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational studyUlf Landmesser, Boris Schmidt, Jens Erik Nielsen-Kudsk, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Plos One|August 10, 2021
Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational StudyKerstin Piayda, Shazia Afzal, Jens Erik Nielsen-Kudsk, et al.
Annals of Medicine|May 3, 2014
Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trialWail Nammas, M J Pekka Raatikainen, Petri Korkeila, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Direct Immunoassay for Free Pregnancy-Associated Plasma Protein A (PAPP-A)Emilia Tuunainen, Juha Lund, Joanna Danielsson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 26, 2021
Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market StudyAdel Aminian, Ole De Backer, Jens Erik Nielsen-Kudsk, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 10, 2017
Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up studyJens Erik Nielsen-Kudsk, Søren Paaske Johnsen, Per Wester, et al.
JACC. Cardiovascular Interventions|May 20, 2019
Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational StudyAdel Aminian, Boris Schmidt, Patrizio Mazzone, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 6, 2020
Comparative data on left atrial appendage occlusion efficacy and clinical outcomes by age group in the Amplatzer™ Amulet™ Occluder Observational StudyXavier Freixa, Boris Schmidt, Patrizio Mazzone, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 11, 2019
Ablation strategies for different types of atrial fibrillation in Europe: results of the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term registryBoris Schmidt, Josep Brugada, Elena Arbelo, et al.
JACC. Cardiovascular Interventions|September 25, 2020
The Impact of CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet StudyGiuseppe Tarantini, Gianpiero D'Amico, Boris Schmidt, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 27, 2017
Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational studyUlf Landmesser, Boris Schmidt, Jens Erik Nielsen-Kudsk, et al.
Pageof 5